EMPAGLIFLOZIN

Clinical trials for EMPAGLIFLOZIN explained in plain language.

Never miss a new study

Get alerted when new EMPAGLIFLOZIN trials appear

Sign up with your email to follow new studies for EMPAGLIFLOZIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

Could a diabetes drug help people with cirrhosis avoid deadly complications?

Disease control Recruiting now

This study tests whether adding empagliflozin (a diabetes drug) to standard carvedilol treatment can prevent serious liver complications or death in people with cirrhosis and a stiff heart condition. About 400 adults aged 18–65 with cirrhosis and left ventricular diastolic dysfun…

Matched conditions: EMPAGLIFLOZIN

Phase: PHASE4 • Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control

Last updated May 11, 2026 20:48 UTC

EMPAGLIFLOZIN

Get alerted when new EMPAGLIFLOZIN trials appear

Could a diabetes drug help people with cirrhosis avoid deadly complications?